2011 to 2022 Saw Decline in Cost-Related Asthma Medication Nonadherence
By Elana Gotkine HealthDay Reporter
TUESDAY, Dec. 10, 2024 -- For adults with asthma, the prevalence of cost-related medication nonadherence (CRN) decreased from 2011 to 2022, according to a study published online Dec. 9 in Thorax.
Chun-Tse Hung, Pharm.D., from Taipei Medical University in Taiwan, and colleagues used data from the 2011 to 2022 National Health Interview Survey to examine trends, prevalence, and determinants of CRN and its impact on asthma control among U.S. adults with asthma. Data were included for 30,793 adults with asthma, representing 8.1 percent of the U.S. population.
The researchers observed a declining trend in the prevalence of CRN among U.S. adults with asthma from 2011 to 2022. Due to cost, about one in six adults with asthma were nonadherent to medications. Factors that were associated with CRN included demographics and comorbidities. The risk for experiencing asthma attacks and emergency department visits for asthma was increased among adults with asthma who had CRN (adjusted odds ratios, 1.95 and 1.63, respectively).
"Since asthma is one of the leading chronic diseases, the burden in cost-related nonadherence to medications highlights the need for appropriate policies and social support to address such problems," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted December 2024
Read this next
GERD Linked to Increased Incidence of Pulmonary Disease
TUESDAY, Aug. 19, 2025 -- The presence of gastroesophageal reflux disease (GERD) is associated with an increased incidence of pulmonary diseases, but this effect may be attenuated...
Six in 10 Children With Asthma Meet Guideline Diagnostic Criteria
THURSDAY, Aug. 14, 2025 -- Roughly two-thirds of children with pediatrician-diagnosed asthma have a confirmed diagnosis in accordance with international guideline criteria...
Study IDs Inflammatory Pathways Contributing to Asthma Exacerbations in Children
TUESDAY, Aug. 12, 2025 -- Inflammatory pathways that contribute to asthma exacerbations have been identified in children with eosinophilic asthma receiving mepolizumab, according...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.